Partnership will expand laboratory and research capabilities to catalyze cure-focused research

MIAMI, May 9, 2022 /CNW/ – The Diabetes Research Institute (DRI), one of the largest and most comprehensive research centers dedicated to finding a biological cure for diabetes now, with the Diabetes Research Institute Foundation Canada (DRIFCAN) and the Alberta Diabetes Institute (ADI) at the University of Alberta, Canada the largest stand-alone research center dedicated to finding a cure for diabetes, today announced the launch of a research partnership to advance efforts to find a cure for diabetes. The partnership is led by Sean KramerCEO of the Diabetes Research Institute Foundation (DRIF) and Melanie HibardCEO of DRIFCAN.

Under this partnership, eminent scholars from both institutions will take on advisory roles as visiting adjunct professors at institute-affiliated universities. dr. Camilo Ricordieminent professor of medicine at University of Miami and director emeritus of the DRI, will advise the University of Alberta as an assistant professor while Dr. James Shapirodirector of the islet transplantation program at University of Alberta and a member of DRI’s Scientific Advisory Board, will partner with the University of Miamialso as associate professor.

“The DRI is unwavering in its mission to find a cure for diabetes. now, and we know that finding the cure must be a collaborative effort that brings together the best researchers in the field,” said Sean Kramer, CEO of the DRIF. “Type 1 diabetes knows no borders or frontiers, and neither should research to find a cure. This one-of-a-kind partnership exponentially expands the research lab and serves as a beacon of hope for all those affected by diabetes.

Two important reasons for hope are islet and STEM cell transplantation, on which Dr. Ricordi and Dr. Shapiro focus their respective research. The process involves removing islet cells from a patient’s pancreas and transplanting them into their liver to help produce insulin. In addition to islet cell research, a ViaCyte and University of Alberta The STEM cell transplant trial is in phase two of a human trial and is showing great promise.

“Our partnership with the DRIF is another important step in the journey towards a cure for diabetes,” said Melanie Hibard, Executive Director of the Diabetes Research Institute Foundation Canada. “We are committed to sharing and advancing groundbreaking research that will make a difference in the lives of countless individuals, families and communities affected by diabetes.”

To learn more about DRIF, visit To learn more about DRIFCAN, please visit

About the Diabetes Research Institute (IRD) and the Foundation

The Diabetes Research Institute (DRI) and Foundation was established for one reason – to cure diabetes – which is and will continue to be the sole purpose until that purpose is achieved. As one of the largest and most comprehensive research centers dedicated to curing diabetes, DRI strives to restore natural insulin production and normalize blood sugar levels without imposing further risks. Researchers have previously shown that transplanted insulin-producing islet cells allow people with type 1 diabetes to live without the need for insulin injections. Some of the DRI’s islet transplant patients have been without insulin for more than 10 years. Funding provided by the Foundation is the driving force that enables DRI scientists to pursue new and innovative ideas and accelerate those discoveries for patients. The Diabetes Research Institute Foundation is the organization of choice for those who want to be part of the cure. For more information, please visit or call 800-321-3437.

About the Diabetes Research Institute of Canada Foundation (DRIFCan)

The Diabetes Research Institute of Canada Foundation (DRIFCan) was created in 2005 to fund the Edmonton Protocol. Dr. Shapiro and his team work at the Alberta Diabetes Institute in University of Alberta in Edmonton, Alberta, Canada. We believe that donors who support diabetes research want maximum funding to go directly to research based on a cure. DRIFCan funds clinical and human trials with Dr. Shapiro and his team.

Media Contact: Kate Rogers
[email protected]


View original content: – fund-research-for-diabetes-treatment-301542967.html

SOURCE Diabetes Research Institute Foundation



View original content:

About The Author

Related Posts